168 related articles for article (PubMed ID: 3020055)
1. Inactivation of poliovirus with beta-propiolactone.
Jiang SD; Pye D; Cox JC
J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
3. Effects of arildone on the immunogenicity of formalin-inactivated polioviruses.
Abe S; Yamaki A; Doi Y; Yoshioka I
Jpn J Med Sci Biol; 1987 Feb; 40(1):1-13. PubMed ID: 3041077
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
[TBL] [Abstract][Full Text] [Related]
5. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on pertussis vaccine batches inactivated with glutaraldehyde, beta-propiolactone, formaldehyde or thiomersal.
Andreescu V; Caffé I; Marion M; Ivan I; David C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):299-308. PubMed ID: 122592
[No Abstract] [Full Text] [Related]
7. The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test.
Jagt HJ; Bekkers ML; van Bommel SA; van der Marel P; Schrier CC
Biologicals; 2010 Jan; 38(1):128-34. PubMed ID: 19716316
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of African horse-sickness virus by betapropiolactone and by pH.
Parker J
Arch Virol; 1975; 47(4):357-65. PubMed ID: 237497
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
Moynihan M; Ladefoged P; Mathiesen L
Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
[TBL] [Abstract][Full Text] [Related]
10. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of mycoplasmas by use of phenol, formalin and beta-propiolactone.
Koski TA; Christianson GG; Cole FL
J Biol Stand; 1976 Apr; 4(2):151-4. PubMed ID: 819443
[No Abstract] [Full Text] [Related]
12. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
14. Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
Tang L; Kang H; Duan K; Guo M; Lian G; Wu Y; Li Y; Gao S; Jiang Y; Yin J; Liu M
Viral Immunol; 2016 Sep; 29(7):430-5. PubMed ID: 27548006
[TBL] [Abstract][Full Text] [Related]
15. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
Jiang SD; Pye D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
[No Abstract] [Full Text] [Related]
16. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
[TBL] [Abstract][Full Text] [Related]
17. Antigenic structure of poliovirus in inactivated vaccines.
Ferguson M; Wood DJ; Minor PD
J Gen Virol; 1993 Apr; 74 ( Pt 4)():685-90. PubMed ID: 7682250
[TBL] [Abstract][Full Text] [Related]
18. Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains.
Kersten G; Hazendonk T; Beuvery C
Vaccine; 1999 Apr; 17(15-16):2059-66. PubMed ID: 10217607
[TBL] [Abstract][Full Text] [Related]
19. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-propiolactone on infectivity and haemagglutinin of the BK virus.
Pitko VM; Pyökäri P; Näse L; Mäntyjärvi R
Acta Pathol Microbiol Scand B; 1975 Apr; 83(2):141-4. PubMed ID: 168727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]